A phase II trial of CC-122 in patients with non-Hodgkin's lymphoma
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Avadomide (Primary)
- Indications Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Celgene Corporation
- 27 Jul 2017 According to Celgene Corporation media release, this trial is expected to initiate in second half of 2017.
- 14 Jan 2016 New trial record
- 11 Jan 2016 Data from this trial is expected in 2016, according to Celgene Corporation media release.